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Abstract: Mesoporous Bioactive Glasses (MBGs) are a family of bioceramics widely investigated for 12 
their putative clinical use as scaffolds for bone regeneration. Their outstanding textural properties 13 
determine high bioactivity when compared with other bioactive materials. Moreover, their great 14 
pore volumes allow these glasses to be loaded with a wide range of biomolecules to stimulate new 15 
bone formation. In this study, an MBG with composition, in mol-%, 80%SiO2–15%CaO–5%P2O5 16 
(Blank, BL) was compared with two analogous glasses containing 4% and 5% of ZnO (4ZN and 17 
5ZN) before and after impregnation with osteostatin, a C-terminal peptide from parathyroid 18 
hormone-related protein (PTHrP107-111). Zn2+ ions were included in the glass for their bone growth 19 
stimulator properties, whereas osteostatin was added by its osteogenic properties. Glasses were 20 
characterized, and their cytocompatibility investigated in pre-osteoblastic MC3T3-E1 cell cultures. 21 
The simultaneous additions of osteostatin and Zn2+ ions provoked enhanced MC3T3-E1 cell 22 
viability and higher differentiation capacity, compared with either raw BL or MBGs supplemented 23 
only with osteostatin or Zn2+. These in vitro results show that osteostatin enhances the osteogenic 24 
effect of Zn2+-enriched glasses, suggesting the potential of this combined approach in bone tissue 25 
engineering applications. 26 
Keywords: Mesoporous glasses; ZnO-additions; Osteostatin loading; Osteosteoblast cell cultures; 27 
Osteogenic effect 28 
 29 
1. Introduction 30 
Bone regeneration is a natural event, but there are certain clinical situations 31 
where this physiological process is impaired. For instance, when either the bone 32 
defect to be repaired is too large or bone has lost its regenerative capacity as occurs 33 
in osteoporosis conditions. In these cases, bone regeneration needs to be favoured 34 
by using bone tissue engineering approaches [1,2]. Such approaches use constructs 35 
formed by 3D porous scaffolds decorated with biological signals and/or bone-36 
forming cells. In the last decade, SiO2–CaO–P2O5 mesoporous bioactive glasses 37 
(MBGs) were proposed as optimum candidates for these scaffolds. These glasses 38 
exhibit bone regenerative properties and highly ordered mesoporous structures 39 
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enabling binding and release bone promoting agents [1,3]. Moreover, the huge 1 
surface area and pore volumes of MBGs yield quicker in vitro responses when 2 
compared with other bioactive materials [4,5].The behaviour of these glasses in a 3 
biological medium can be improved by incorporating bioactive metal ions in the 4 
glass network. This is the case of Zn2+ ions which exhibit osteogenic and angiogenic 5 
features as well as antioxidant, cancer preventive and antimicrobial activities [6-10]. 6 
In this regard, since bacterial infection [11] is an important problem after bone 7 
implants surgery [12,13], the combination of the regenerative properties of MBGs 8 
with the beneficial effects of Zn2+ ions has potential interest in bioengineering 9 
applications [14].  10 
Following the bone tissue engineering principles, the bioactivity of a scaffold 11 
can be improved by loading with osteogenic agents such as parathyroid hormone 12 
(PTH)-related protein (PTHrP), which is emerging as an interesting promoter of 13 
bone regeneration. PTHrP contains an N-terminal 1–37 region homologous to PTH 14 
and a C-terminal PTH-unlike region containing the highly conserved 107–111 15 
sequence osteostatin [15]. N-terminal PTHrP analogues have been shown to induce 16 
bone anabolism in rodents and humans upon systemic intermittent administration 17 
[16,17]. On the other hand, osteostatin has anti-resorptive activity [18], but also 18 
exhibits osteogenic features in vitro and in vivo [19-24]. Moreover, it has recently 19 
been shown that osteostatin coating onto various types of ceramic implants 20 
accelerates healing of critical and noncritical bone defects in the long bones of adult 21 
normal and osteoporotic rabbits and in rats [25-29]. Therefore, recent findings point 22 
to osteostatin as an attractive small peptide for consideration in a bone tissue 23 
engineering scenario. 24 
In this study, the biological consequences of the concurrent inclusion of ZnO 25 
and osteostatin impregnation in MBGs were investigated. Three MBGs were 26 
synthesized, all with a basic composition of 80%SiO2–15%CaO–5%P2O5 (mol-%), 27 
containing or not (Blank, BL) 4% or 5% ZnO, respectively (4ZN and 5ZN). These 28 
compositions were selected based on our previous studies [14], which were 29 
consistent with reported for other glass systems showing 5% as the maximum 30 
content of ZnO enhancing osteoblast cell development without being cytotoxic [30-31 
32]. MBG powders were processed as disk-shape pieces for several in vitro studies: 32 
uptake and release of osteostatin; assays in simulated body fluid (SBF); release of 33 
the inorganic ions, calcium, phosphate and zinc from disks to the surrounding 34 
medium; and bioactivity in mouse pre-osteoblastic MC3T3-E1 cell cultures. This 35 
approach allowed us evaluate the putative advantage of loading osteostatin onto 36 
ZnO-containing glasses to produce an optimal biomaterial for bone regeneration. 37 
2. Experimental 38 
2.1 Synthesis of the MBGs as powders and processing into disks 39 
The synthesis of the MBGs, was made through the EISA (Evaporation-Induced 40 
Self Assembly) method, using 4.5 g Pluronic® P123 as surfactant, 85 mL ethanol 41 
(99.98%), as solvent, and 1.12 mL 0.5 N HNO3 as catalyst. The process was carried 42 
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out for 1 h under stirring at 250 rpm, covering the flask with Parafilm® to prevent 1 
the solvent evaporation. Then, the appropriate amounts of tetraethyl orthosilicate 2 
(TEOS), Ca(NO3)2·4H2O, triethyl phosphate (TEP) and Zn(NO3)2·6H2O were added 3 
as SiO2, CaO, P2O5 and ZnO sources, respectively (all reagents from Sigma-Aldrich, 4 
St. Louis, MO). Thus, 8.9 mL TEOS were slowly added for 3 h, followed by the 5 
addition of 0.71 mL TEP for another 3 h period. Next, 1.1 g Ca(NO3)2·4H2O and the 6 
required amounts of Zn(NO3)2·6H2O depending on the designed ZnO content (0.60 7 
g for 4ZN or 0.75 g for 5ZN) were also added. The solution was continuously stirred 8 
at 250 rpm during the synthesis process. The solution was left overnight (14 h), then 9 
it was distributed in Petri dishes (30 mL/plate), and let the ethanol to evaporate at 25 10 
°C for 7 d. Thereafter, the resulting transparent membrane was withdrawn and 11 
heated for 6 h at 700 °C (with a heating ramp of 1 °C/min). Finally, materials were 12 
gently milled on a glass mortar to prevent deterioration of the mesoporous order, 13 
and sieved through a 40 μm mesh. For the in vitro assays, the powders were 14 
conformed into disks (6 mm diameter, 2 mm height) obtained by compacting 70 mg 15 
of MBG powders with 5 MPa of uniaxial pressure. 16 
2.2 Physicochemical characterization of samples   17 
The samples were characterised by CHN elemental analysis in a Macroanalyser 18 
Leco CNS-2000-I; Thermogravimetric and Differential Thermal analysis (TG/DTA) 19 
in the 30 oC to 900 oC interval (air flow: 100 mL/min) in a Perkin Elmer iPyris 20 
Diamond system; Fourier transformed infrared (FTIR) spectroscopy in a Thermo 21 
Scientific Nicolet iS10 apparatus, equipped with a SMART Golden Gate attenuated 22 
total reflection ATR diffuse reflectance accessory; Small-Angle X-ray diffraction, SA-23 
XRD, in a X'pert-MPD system equipped with Cu Kα radiation in the 0.6 to 8o 2θ 24 
range and Transmission Electron Microscopy (TEM), in a JEM-2100 JEOL 25 
microscope operating at 200 kV. Samples were ultrasonically dispersed in n-butanol 26 
and deposited in a copper grid coated with a holed polyvinyl-formaldehyde layer 27 
for TEM analysis.  28 
Moreover, samples were characterised by Nitrogen adsorption and solid-state 29 
Nuclear Magnetic Resonance (NMR). Nitrogen porosimetry was performed in a 30 
Micromeritics ASAP 2020. Samples were previously degassed 24 h at 120 oC under 31 
vacuum. The surface areas were calculated by the Brunauer–Emmett–Teller (BET) 32 
method [33], and the pore size distributions by the Barret–Joyner–Halenda (BJH) 33 
method [34]. Surface functionalization was studied by solid state single pulse magic 34 
angle spinning nuclear magnetic resonance (SP MAS NMR). The 29Si and 31P spectra 35 
were obtained on a Bruker Avance AV-400WB spectrometer equipped with a solid 36 
state probe using a 4 mm zirconia rotor and spun at 10 kHz for 29Si and 6 kHz in the 37 
case of 31P. Spectrometer frequencies were set at 79.49 and 161.97 MHz for 29Si and 38 
31P, respectively. Chemical shift values were referenced to tetramethylsilane (TMS) 39 
for 29Si and H3PO4 31P. The time period between accumulations were 5 and 4 s for 40 
29Si and 31P, respectively, and the number of scans was 10,000.  41 
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2.3 In vitro studies 1 
In vitro tests were carried out in MBGs disks sterilized for 20 min under UV 2 
radiation (10 min/face) in a laminar flux cabinet. The disks maintained their stability 3 
without crumbling even for soaking times as long as 21 d in the assays performed in 4 
SBF.     5 
2.3.1 Adsorption and release of osteostatin  6 
For the adsorption assay, the disks in 24-well plates were incubated with 1 mL 7 
of phosphate-buffered saline (PBS), pH 7.4, containing or not (control) 100 nM 8 
osteostatin. Samples were left under stirring at 400 rpm, at 4 °C. Osteostatin 9 
adsorption in each type of tested MBG after 24 h was calculated based on the 10 
peptide removed from the liquid medium; whereas osteostatin release was 11 
measured by soaking the peptide-loaded disks for different times (1, 2, 24, 48, 72 12 
and 96 h) in PBS also under stirring, at 37 °C. The amount of osteostatin in PBS 13 
medium was measured by UV spectrometry at 280 nm using a NanoDrop ND-2000 14 
(NanoDrop Technologies, Thermo Fisher Scientific, Wilmington, DE, USA).  15 
2.3.2 Assays in SBF  16 
In vitro bioactivity tests were carried out by soaking the disks for 6 h, 24 h, 3 d, 7 17 
d, 14 d and 21 d in SBF, pH 7.4, at 37 °C [35]. SBF was previously filtered through a 18 
0.22 μm filter to prevent bacterial contamination. The disks were placed in 19 
polyethylene flasks containing 13 mL of SBF, according to the equation Vs = Sa/10 20 
(being Vs the SBF volume in mL and Sa the external surface area of the disks in 21 
mm2). Inside the SBF, the disks were located in vertical position by including them 22 
in "baskets” fabricated with Platinum wire. Two replicas by material and time and a 23 
control with only SBF were included.   24 
Before and after the assays, disks were characterized by wide angle X-ray 25 
diffraction, XRD, 2θ from 10 to 70o, in an X'Pert-MPD (Philips) system; FTIR 26 
spectroscopy in a Thermo Scientific Nicolet iS10 (KBr pellet method); and SEM in a 27 
JSM-6400 (JEOL) microscope coupled with an EDX spectroscopy system. Moreover, 28 
changes in Ca2+ concentration and pH of the liquid medium were assessed with an 29 
ILyte® electrode ion selective system (Diamond Diagnostics, MA, USA). An in vitro 30 
bioactive behaviour in SBF is generally identified by the deposition on the material 31 
surface of amorphous calcium phosphate (ACP) layer that later on crystallized as 32 
hydroxycarbonate apatite (HCA) nanocrystals analogous to those in bone [36, 37].  33 
2.3.3 Ions release from disks  34 
The release of ions was investigated by soaking the MBG disks in 2 mL of 35 
Dulbecco's modified Eagle medium (DMEM) (Sigma-Aldrich) supplemented with 36 
10% fetal bovine serum (FBS) and antibiotics (100 U mL-1 penicillin, 100 mg mL-1 37 
streptomycin) (usually called “complete medium”) at 37oC for different times 38 
between 24 h and 5 d. For each disk sample, the cumulative amounts of Ca, P and 39 
Zn released to the complete medium was determined by inductively coupled 40 
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plasma/optical spectrometry (ICP/OES) using an OPTIMA 3300 DV device (Perkin 1 
Elmer). The concentration of each ion was determined from three replicates on the 2 
same solution split into two independent experiments. 3 
2.3.4  Culture cell studies 4 
Cell culture experiments were performed using the mouse pre-osteoblastic 5 
MC3T3-E1 cell line (subclone 4, CRL-2593; ATCC, Mannassas, VI) [25,27]. The 6 
different disks tested were placed into 6 and 24-well plates before cell seeding at 7 
20,000 cells/cm2 in 2 mL of α-minimum essential medium containing 10% FBS, 50 8 
μg/mL ascorbic acid, 10 mM ß-glycerol-2-phosphate and 1% penicillin–streptomycin 9 
at 37 oC in a humidified atmosphere of 5% CO2, and incubated for different times 10 
between 1 and 13 d. As controls, wells without disks were used. Medium was 11 
replaced every other day. 12 
Cell number were determined using the CellTiter 96® AQueous Assay 13 
(Promega, Madison, WI), a colorimetric method for determining the number of 14 
living cells in the culture. Cells were cultured without (control) or with the tested 15 
disks for 10 h (only measured on the disks surface) or for 2 and 5 d (measured in 16 
both the disks and well surface). Next, 40 μl of CellTiter 96®AQueous One Solution 17 
Reagent [containing 3- (4,5-dimethythizol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-18 
sulfophenyl)-2H-tetrazolium salt (MTS) and an electron coupling reagent 19 
(phenazine ethosulfate) that allows its combination with MTS to form a stable 20 
solution for 4 h ] was added to each well (200 μl) in contact with the cells. The 21 
quantity of formazan product as measured by the amount of 490 nm absorbance (in 22 
a Unicam UV-500 spectrophotometer) is directly proportional to the number of 23 
living cells in culture. In addition, in some cell cultures, at 2 d, cells were trypsinized 24 
and counted in a hemocytometer to determine cell death by Trypan blue exclusion. 25 
Alkaline phosphatase (ALP) activity was measured in MC3T3-E1 cell extracts 26 
obtained with 0.1% Triton X-100 at day 5 of culture, using p-nitrophenylphosphate 27 
as substrate, as previously described [38]. ALP activity was normalized to the cell 28 
protein content, determined by the Bradford’s method using bovine serum albumin 29 
as standard.  30 
Matrix mineralization was measured in MC3T3-E1 cell cultures by alizarin red 31 
staining, as described [26]. After incubation with the different disks for 12 d, cells 32 
were washed with PBS, and fixed with 75% ethanol for 1 h at room temperature. 33 
Cell cultures were stained with 40 mM alizarin red (pH 4.2) for 10-30 min at room 34 
temperature. Then, cells were washed with distilled water, and the stain was 35 
dissolved with 10% cetylpyridinum chloride in 10 mM PBS and measuring 36 
absorbance at 620 nm in a Unicam UV-500 spectrophotometer. 37 
Total RNA was isolated from MC3T3-E1 cells by a standard procedure (Trizol, 38 
Invitrogen, Groningen, The Netherlands), and gene expression was analysed by 39 
real-time PCR using a QuantStudio 5 Real-Time PCR System (Thermo Fisher 40 
Scientific, Wilmington, DE, USA). Real-time PCR was done using mouse-specific 41 
primers and TaqManMGB probe for Runx2 (Assay-by-DesignSM, Applied Biosystems, 42 
CA, USA). The mRNA copy numbers were calculated for each sample by using the 43 
Nanomaterials 2018, 8, x FOR PEER REVIEW  6 of 22 
cycle threshold (Ct) value. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 1 
rRNA (a housekeeping gene) was amplified in parallel with Runx2. The relative 2 
gene expression was represented by 2−ΔΔCt, where ΔΔCt = ΔCttarget gene – ΔCtGAPDH. The 3 
fold change for the treatment was defined as the relative expression compared with 4 
control, calculated as 2−ΔΔCt, where ΔΔCt = ΔCtreatment – Δccontrol [21]. Runx2 5 
(Mm00501578 _m1; NM_001146038.2). GAPDH (Mm99999915_g1; 6 
NM_001289726.1). 7 
Cell morphology was studied into disks using an Eclipse TS100 inverted optical 8 
microscope (Nikon) after 24 h. Fluorescence microscopy was also carried out for the 9 
observation of attached cells onto the disks. After samples were fixed and 10 
permeabilized, they were incubated with Atto 565-conjugated phalloidin (dilution 11 
1:40, Molecular Probes) which stains actin filaments. Then, samples were washed 12 
with PBS and the cell nuclei were stained with l M diamino-20-phenylindole in PBS 13 
(DAPI) (Molecular Probes). Fluorescence microscopy was performed with an EVOS 14 
FL Cell Imaging System equipped with tree Led Lights Cubes (kEX (nm); kEM 15 
(nm)): DAPI (357/44; 447/60), RFP (531/40; 593/40) from AMG (Advance Microscopy 16 
Group). 17 
 18 
2.3.5 Statistical analysis 19 
Results are expressed as mean ± SEM (SEM: standard error of mean). 20 
Statistical evaluation was carried out with nonparametric Kruskal-Wallis test and 21 
post-hoc Dunn´s test, when appropriate. A value of p<0.05 was considered 22 
significant. 23 
 24 
3. Results and discussion 25 
3.1 Glass powders characterization 26 
Prior to obtaining the disks that were used for the in vitro tests, the MBG 27 
powders were characterized by several experimental techniques. CHN elemental 28 
analysis, TG/DTA and FTIR spectroscopy showed the successful synthesis of glasses 29 
confirming the entire removal of surfactant and nitrate groups coming from Ca2+ 30 
and Zn2+ sources, and the MBG stabilization under ambient conditions after the last 31 
step of synthesis, namely the treatment at 700 oC. In addition, MBGs powders were 32 
characterised by SA-XRD and TEM, to assess if they exhibited or not ordered 33 
mesoporosity, and by Nitrogen adsorption to determine their textural properties, 34 
i.e. specific surface area and porosity.  35 
Figure 1A shows the SA-XRD patterns of BL, 4ZN and 5ZN powders. As is 36 
observed, BL pattern exhibits a sharp diffraction maximum at 1.3o, indicative of 37 
mesoporous order, and a shoulder at around 2.0o in 2θ. According to our previous 38 
studies, the sharp maximum was assigned to the (10) reflection of a 2D hexagonal 39 
phase formed by the mesopores arrangement and the shoulder to the low intensity 40 
(11) and (20) reflections of this phase [39]. In contrast, in the 4ZN and 5ZN patterns, 41 
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only diffuse maximum and shoulders at about 1.3o in 2θ were observed. This type of 1 
patterns is generally present in samples exhibiting worm-like order [40]. 2 
 3 
 4 
Figure  1. Physicochemical characterization of Zn-free (BL) and Zn-substituted (4ZN 5 
and 5ZN) MBG powders by: (A) SA-XRD; (B) TEM; and (C) N2 adsorption. Inset table: 6 
calculated textural properties, i.e. specific surface area (SBET), volume of pores (VP) and 7 
pore diameter (DP). 8 
Figure 1B shows the high resolution TEM images of the MBG powders. BL and 9 
4ZN images mainly show ordered areas confirming the presence of a mesoporous 10 
ordered structure. In addition, in these samples minority regions with disordered 11 
worm-like structure are present. In the TEM image of 5ZN, most part of the 12 
observed areas exhibited worm-like order. Thus, TEM results confirmed those 13 
obtained by SA-XRD, demonstrating that the order of mesopores decreases with the 14 
presence of Zn2+ ions in the glass network.  15 
To assess whether this decrease in the mesoporous order by Zn2+ ions was 16 
accompanied by a significant variation in the textural parameters, the MBG 17 
powders were characterized by Nitrogen adsorption. As observed in Figure 1C, the 18 
isotherms of the three samples are type IV, characteristic of mesoporous materials. 19 
Moreover, the curves exhibit a type H1 cycle of hysteresis, indicative of the presence 20 
of cylindrical pores opened at both ends. Thus, BL, 4ZN and 5ZN exhibited 21 
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analogous features in terms of the type and shape of the pores present. The 1 
aforementioned textural properties of these glasses were then calculated from the 2 
isotherms. As seen in Figure 1C, inset, only moderate decreases took place in the 3 
textural properties as consequence of the inclusion of Zn2+ ions in the glass. Thus, 4 
the specific surface area of 372 m2/g of BL slightly decreased to 362 and 340 m2/g in 5 
4ZN and 5ZN, respectively. Furthermore, the pore volume experienced also 6 
moderate decreases from 0.47 to 0.38 and 0.39 cm3/g, and the average pore diameter 7 
from 4.7 to 4.2 and 4.3 nm, respectively, in Zn-containing glasses. 8 
29Si and 31P solid state MAS NMR measurements were carried out to investigate 9 
the environments of the network formers and network modifiers species at atomic 10 
level in the MBGs (Figure 2). The NMR analysis will be related later with the release 11 
of Zn2+ ions in the in vitro assays with cells. In the Figure, Q2, Q3, and Q4 represent 12 
respectively, the silicon atoms (denoted Si*) in (NBO)2Si*–(OSi)2, (NBO)Si*–(OSi)3, 13 
and Si*(OSi)4 (NBO = nonbonding oxygen) [41], whereas Q0 and Q1, represent 14 
respectively the phosphorus atoms (denoted P*) in the PO43- species, (NBO)3P*–(OP) 15 
and (NBO)2-P*–(OP)2 (NBO relative to another P atom). The chemical shifts, de-16 
convoluted peak areas, and silica network connectivity <Qn> for each glass 17 
composition were collected in Table 1.  18 
 19 
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Figure 2. (A) Solid-state 29Si single-pulse and 31P single-pulse MAS-NMR spectra of BL, 1 
4ZN and 5ZN. Qn unit areas were calculated by Gaussian line-shape deconvolution and 2 
displayed in green. (B) Schematic view of Q2 Zn and Q4 Zn assignments from 29Si MAS 3 
NMR. 4 
In the 29Si NMR spectra, the signals at -110 to -112 ppm region were assigned to 5 
Q4; at -101 to -103 ppm to Q3; and at -92 ppm to -96 ppm to Q2. BL sample is 6 
characterized by a high percentage of Q4 and Q3 species, and the network 7 
connectivity, <Qn>, calculated for this sample of was 3.57. This value is lower than 8 
reported for a sol-gel glass with identical composition that was 3.75 [40]. The 9 
relatively low values of <Qn> in MBGs is one of their features that can explain the 10 
quick in vitro bioactive response of this family of glasses.  11 
Table 1. Chemical shifts (CS) and relative peak areas of MBGs obtained by 29Si and 31P NMR. Areas 12 
of the Qn units were calculated by Gaussian deconvolution, the relative populations were expressed 13 
as % and the full width at half maximum, fwhm, was also included.   14 
 15 
As is observed in the Table, the inclusion of 5.0% ZnO produced an increase of 16 
<Qn>, 3.67, compared with BL whereas in 4ZN a slight decrease, 3.55, was observed. 17 
These results were explained considering that when a 4.0% of ZnO was added, Zn2+ 18 
ions behaved as network formers with tetrahedral coordination [ZnO4] which 19 
exhibit negative charge (2-). These tetrahedra attract Ca2+ ions that accordingly 20 
behave as charge compensators instead of as network modifiers (Figure 2B). 21 
Regarding 5ZN, the higher percentage of Q4 species in this sample indicates a 22 
decrease in the NBO which supposes a higher contribution of Zn2+ as network 23 
former compared with 4ZN explaining the highest value of <Qn> for 5ZN. However, 24 
the amounts of ZnO were not high enough to increase substantially the 25 
depolymerisation of network in 4ZN and 5ZN with respect to BL, explaining the 26 
similar values of <Qn> obtained for the three samples (Table 1) that agree with 27 
previously reported for BL and 4ZN [14]. The increasing FWHM is due to a larger 28 
distribution of isotropic values of the chemical shift, with is caused by a decreasing 29 
short range order of the framework structure [42]. The tetrahedral symmetry of the 30 
Q4 units in BL sample respect to 4ZN and 5ZN samples indicates an isotropic 31 
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BL -112 61.7 8.04  -103 33.8 9.4  -92 4.4 18.5  3.57  1.5 91.2 5.7  -5.3 8.8 13.0 
4ZN -112 68 10.6  -102 18.9 6.0  -94 12.9 10.3  3.55  2.0 93.7 7.7  -6.9 6.3 6.1 
5ZN -110 75.7 11.8  -103 15.4 4.3  -93.5 8.92 11.6  3.67  2.4 92.9 5.8  -7.5 7.0 7.4 
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structure when no zinc is added to the MBGs. In addition, the crystallinity of Q3 and 1 
Q2 are slightly greater when zinc is present in the samples.  2 
On the other hand, the 31P NMR spectra show a maximum of ∼2 ppm assigned 3 
at the Q0 environment of amorphous orthophosphate (Figure 2A) and a second 4 
weak signal from -5.2 ppm to -7.5 ppm when ZnO % in MBGs increases [43]. This 5 
resonance falls in the range of Q1 tetrahedra and can be assigned to P–O–Si 6 
environments as previously reported [44,45]. Thus, P is mainly present as 7 
orthophosphate units but Zn inclusion caused a slight decrease of Q1 units 8 
percentage, and its chemical shift pass from -5.2 ppm for BL to -7.5 ppm for 5ZN, 9 
suggesting a partial conversion of P–O–Si units into P–O–Zn units due to Zn2+ ion 10 
acting as a network former with more anisotropic structure than Q1 of BL sample. 11 
The formation of P–O–Zn was proposed for bioactive melt glasses where a shift 12 
towards lower ppm was detected when the ZnO % in the glass increased [46].   13 
In summary, the characterizations of the MBGs powders has shown the 14 
decrease of the order of mesopores when ZnO in glasses increased. However, the 15 
textural properties of ZnO-containing MBGs remained similar to un-doped MBG 16 
(BL) with values of surface area and porosity higher than conventional sol-gel 17 
glasses [47]. Moreover, the NMR results will allow to understand the release of Zn2+ 18 
ions during the in vitro assays with cells.    19 
3.2 Textural properties of MBG disks 20 
As previously mentioned, the disks used for the in vitro tests were obtained by 21 
compacting the powders at 5 MPa, there it was necessary to characterize the MBG 22 
disks by nitrogen adsorption to evaluate the textural properties after the processing. 23 
As observed in top, left of Figure 3 the isotherms showed identical features than 24 
MBG powders showed in Figure 1C.  Moreover, at the top right of Figure 3, the 25 
corresponding pore size distributions are shown.  26 
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Figure 3. N2 adsorption-desorption isotherms (left) and pore size distribution (right) of 2 
BL, 4ZN and 5ZN disks before (upper panels) and after (lower panels) being loaded 3 
with osteostatin.  4 
Table 2 allows the comparison of the textural properties of MBG powders and 5 
disks. As it is observed disks exhibited moderate decreases of the textural properties 6 
compared with the corresponding powders. Thus, SBET values, between 372 and 340 7 
m2/g in powders, decreased to values in the range 287 - 280 m2/g in the disks; and 8 
the pore volume  decreased from 0.47 - 0.38 cm3/g to 0.38 - 0.22 cm3/g. Therefore, 9 
textural propertied of disks remained high enough to host osteostatin molecules. 10 
The textural properties of disks after be loaded with osteostatin are also included in 11 
the Table. As is observed additional decreases of the specific surface area and pore 12 
volume were detected confirming the loading of the osteostatin into the MBGs. 13 
Finally, the composition of disks was determined by EDX obtaining the values 14 
shown at the right of the Table 2. These values showed a good agreement with the 15 
nominal composition of the glasses included between brackets in the Table.  16 
Table 2. Textural properties of the glasses as powders, disks and disks loaded with osteostatin. (SBET: 17 
specific surface area; VT: pore volume; DP: pore diameter). At the right, experimental compositions of 18 
samples determined by EDX and nominal compositions indicated between brackets.  19 
 
              Powders    Disks Disks + osteostatin Composition (EDX) 
atomic % SBET 
m2/g 
VT  
cm3/g 
DP  
nm 
SBET  
m2/g 
VT 
cm3/g 
DP  
nm 
SBET  
m2/g 
VT 
cm3/g 
DP  
nm      SiO2             CaO          P2O5              ZnO 
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3.3 Uptake and release of osteostatin 2 
After soaking the MBG disks in a solution 100 nM of osteostatin in PBS for 24 h, 3 
the mean uptake of the peptide was 63 % (BL), 70 % (4ZN) and 71 % (5ZN) (Figure 4 
4A), equivalent to 0.8, 0.9 and 0.95 μg/g per disk, respectively.  5 
On the other hand, the osteostatin released from the loaded disks to the 6 
medium after 1 h was 73 % (BL), 67 % (4ZN) and 68 % (5ZN). After 24 h, it was 95% 7 
(BL) or 90% (4ZN and 5 ZN) and it was virtually 100 % for the three MGBs at 96 h 8 
(Figure 4B). It is pertinent to mention here that minimum amounts of this peptide 9 
(even in the sub-nM range) were efficient to induce osteogenic activity [26-28].  10 
As it was told, the effect of loading osteostatin in the textural properties of disks 11 
was determined. Figure 3 includes the N2 adsorption isotherms (bottom, left) and 12 
pore size distributions (bottom, right) of osteostatin-loaded disks. As is observed in 13 
Table 2, a slight decrease in the surface area and porosity was observed in the MBG 14 
disks as a consequence of osteostatin loading. These results suggests that a part of 15 
the peptide loading takes place inside the pores, but without affecting the ordering 16 
of the mesopore channels.   17 
If we assume that the release mechanism of osteostatin was diffusion through 18 
the mesopores and considering the low solubility of the glasses at the medium pH 19 
(7.4), the peptide release could be described by a deviation from the theoretical first-20 
order behaviour of the Noyes–Whitney equations as described by Eq. (1) [48,49]:   21 
                    Wt / W0 =A·(1 – expk·t)           (Eq. 1) 22 
Where Wt stands for the peptide mass released at time t; W0 represents the 23 
maximum initial mass of the peptide inside the pores; A is the maximum amount of 24 
peptide released; and k is the release rate constant, which is independent of peptide 25 
concentration and gives information about the solvent accessibility and the 26 
diffusion coefficient through mesoporous channels. 27 
BL 372 0.47 4.7 287 0.38 4.7 244 0.32 4.6 
77.0± 4 
(80) 
6.1± 0.6 
(5) 
16.8±2  
(15) 
-- 
4ZN 352 0.38 4.2 280 0.30 3.7 221 0.24 3.6 
74.3± 1 
(77) 
7.0±2  
(4.8) 
4.3±0.3 
(14.4) 
4.2±0.2 
(4) 
5ZN 340 0.39 4.3 285 0.22 3.3 208 0.17 3.1 
68.1±6  
(76) 
9.2±4 
(4.8) 
17.3±3 
(14.3) 
5.3±0.2 
(5) 
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 1 
Figure 4. Osteostatin uptake at 24h (A), and its release profiles measured at different 2 
times (B), for BL, 4ZN and 5ZN disks. Points tracing the curve are the means of three 3 
experiments. 4 
This model was successfully applied for the release of different drugs from 5 
insoluble mesoporous matrices with similar structure [48]. According to this model, 6 
peptide release is faster within the first 24 h, reaching a stationary phase after 48 h. 7 
This deviation could be due to several factors, such as the peptide volume, the 8 
distortion of the mesopore channels and/or the release of peptide molecules 9 
adsorbed on the external surface of the matrices. 10 
This divergence has been dealt with by the introduction of an empirical non-11 
ideally factor δ in Eq. (2) [50]:  12 
wt / w0 = A(1 -expk1·t) δ                 Eq. (2)    13 
The values of this non-ideally factor δ range from 1 to 0 for materials that either 14 
follow first-order kinetics or initially release the peptide molecules located on the 15 
external surface of the matrices. The obtained data were fitted using this semi-16 
empirical first-order model, and the release parameters are shown in Table 3. 17 
According to this model, δ gives an idea of the degree of fidelity of this 18 
approximation. In all tested MBG matrices δ value is low and similar, indicating 19 
that a relatively large percentage of osteostatin molecules released from the external 20 
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surface of the MBGs. Moreover, the percentage of osteostatin released was maximal, 1 
indicating virtually no osteostatin long retention by all these MBGs. 2 
Table 3. Kinetic parameters of osteostatin release from BL, 4ZN and 5ZN materials. (w0: 3 
initial loaded mass: µg ost/g MBG; A: maximum amount of peptide released; k1: release 4 
rate constant; δ: kinetic non-ideality factor; R: goodness of fit.  5 
 
w0 (µg/g) A (%) k1(*103) (h-1) δ R 
BL 0.80 99.3±3.3 37.7±3 0.14±0.04 0.996 
4ZN 0.90 99.7±3.9 31.5±3 0.13±0.04 0.998 
5ZN 0.95 99.6±3.9 31.5±4 0.12±0.07 0.996 
 6 
3.4 In vitro bioactivity assay 7 
The different MBG disks before and after soaking in SBF for different times 8 
were characterized by FTIR. This is a very sensible technique for detecting the 9 
formation of amorphous calcium phosphate (ACP) and HCA by evaluating the 10 
region of the spectra at around 600 cm-1. The presence of a band in this region is 11 
characteristic of ACP, and the split of this band in bands at 560 and 603 cm-1 is 12 
indicative of phosphate in a crystalline environment like the one in nano-HCA [51].  13 
As observed in Figure 5, the behaviour of BL in SBF is different from that of 14 
4ZN and 5ZN. Thus, for the Zn-free MBG, the band at 600 cm-1 was visible at 6 h of 15 
incubation, and the bands of HCA were already detected at 1 d. For longer times, 16 
like 3 d, the FTIR spectra did not suffer additional changes. However, for 4ZN and 17 
5ZN only the band of ACP was observed after 7 d of treatment and the two bands of 18 
HCA were not detected even for soaking days as long as 21 d. These results had 19 
already been described for bioactive MBGs to which the ZnO additions impeded the 20 
formation of HCA in regular SBF (osteostatin-free) [39]. This result was thought to 21 
be a consequence of the initial formation of amorphous calcium zinc phosphate, 22 
unable to crystallize as HCA. However, in the present study we demonstrated that, 23 
although the impregnation of MBGs with 100 nM osteostatin solution exerts a 24 
remarkable effect in the MBGs behaviour in the presence of cells (see the next 25 
sections), osteostatin was not found to affect the in vitro formation of ACP or HCA 26 
on the tested glasses in SBF. 27 
 28 
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Figure 5. FTIR spectra of BL, 4ZN and 5ZN after different times in SBF with 100 nM of 2 
osteostatin. The ellipse highlights the bands of phosphate in a crystalline environment.  3 
SEM analysis confirmed the FTIR results. Thus, Figure 6 shows the SEM 4 
micrographs of BL, 4ZN and 5ZN before and after being soaked 7 d in SBF. As is 5 
observed, after this time only BL appears coated by a layer of spherical particles 6 
with the characteristic morphology of bone-like HCA. This morphology was 7 
developed from the initially formed flocculent shape of ACP. In contrast, for 4ZN 8 
and 5ZN disks no HCA layer was found after 7 d immersed in SBF although a new 9 
material was observed on the 4ZN surface. However, the high intensity of the 10 
calcium and phosphorous peaks in the EDX spectra of BL, compared to the other 11 
samples, supports the interpretation that there HCA preferentially shows up on the 12 
BL sample. These results were analogous to those reported for Zn-containing MBGs 13 
performed in pure SBF showing the inhibitory effect of Zn2+ ions in the HCA 14 
crystallization [39].  In the present study we obtained the identical results 15 
demonstrating the null effect of osteostatin additions in the assays in the acellular 16 
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SBF, in spite of the important effect that exerts in the presence of cells as it will be 1 
described in the following sections.    2 
 3 
Figure. 6 SEM micrographs and EDX spectra of BL 4ZN and 5ZN MBG disks, before 4 
and after be soaked for 7 d in SBF. 5 
3.5. Degradability of disks in complete medium 6 
To better understand the MBGs cytocompatibility, the release of calcium, 7 
phosphorus and zinc ions from osteostatin-loaded disks after be soaked until 130 h 8 
in complete medium were measured. As it is shown in Figure 7, in BL, calcium and 9 
phosphorous concentration in solution was slightly lesser than in 4ZN and 5ZN 10 
which can be explained by the HCA layer formed on BL as it was mentioned in the 11 
previous section. This variation fit well with the formation of ACP during this 12 
interval. Moreover, the Zn concentration in Zn-substituted scaffolds increased until 13 
day 5 in both 4ZN and 5ZN disks, reaching a value of 4.6 and 5.3 ppm, respectively; 14 
consistent with the slightly higher network polymerization of 5ZN material 15 
compared to 4ZN, thus releasing less amount of Zn2+ to the medium.  16 
 17 
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Figure 7. Evolution of cumulative calcium, phosphorus and zinc content of osteostatin-1 
loaded disks as a function of time in complete medium.  2 
3.6 Cell culture studies  3 
We next examined and compared the osteogenic activity conferred by Zn2+ and 4 
osteostatin to these MBGs using MC3T3-E1 pre-osteoblastic cell cultures. We first 5 
showed that cell number onto the disks surface at 10 h of culture was increased in 6 
both 4ZN and 5ZN materials loaded with osteostatin (Figure 8A). At day 5 of cell 7 
culture, the cellular morphology was not modified by any tested material (Figure 8 
8B). Consistent with this result, although Zn2+ in these MBGs failed to affect cell 9 
number, the presence of osteostatin in both 4ZN and 5ZN materials increased 10 
significantly this parameter after 5 d of culture (Figures 9A and B). This pattern of 11 
bioactivity matched the amount of Zn2+ released to the surrounding medium (Figure 12 
7). Thus, although osteostatin loaded into BL disks exhibited a tendency (but not 13 
significant) to increase cell viability (Figures 9A and B), this was only clearly 14 
displayed with the peptide-coated 4ZN and 5ZN glasses. None of the tested 15 
materials induced significant cell death (about 1%), assessed by Trypan blue 16 
exclusion, in these cell cultures (data not shown). 17 
 18 
 19 
Figure. 8. MC3T3-E1 cell number onto BL, 4ZN and 5ZN disks measured at 10 h of cell 20 
culture (A). Results are means ± SEM of three measurements in triplicate (*p < 0.05) vs 21 
the corresponding unloaded disks. Absorbance was measured at 490 nm, directly 22 
proportional to the number of living adherent cells. Cell morphology evaluation 23 
performed by light microscopy onto BL, 4ZN and 5ZN disks at day 5 of cell culture (B). 24 
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Cells were stained with DAPI (blue) for the visualization of the cell nuclei and 1 
phalloidin-565 (red) for the visualization of cytoplasmic F-actin filaments. 2 
We next evaluated the capacity of these MBGs to affect osteoblastic cell 3 
differentiation. The expression of the early osteoblast differentiation marker Runx2 4 
was increased by the presence of osteostatin in each type of MBG disks at day 5 of 5 
MC3T3-E1 cell culture (Figure 9C). Moreover, while 4ZN or 5ZN disks had minimal 6 
effect on to affect ALP activity or matrix mineralization in these cells, coating with 7 
osteostatin increased these differentiation parameters, mainly in the 4ZN material 8 
(Figures 9D and E).  9 
In summary, in vitro studies demonstrated that MBG disks can be loaded with 10 
osteostatin, which was mostly released in 24 h. Osteostatin improved the 11 
cytocompatibility of Zn-containing MBGs by enhancing osteoblastic proliferation 12 
and differentiation without affecting their HCA formation capability. Further 13 
studies in vitro and in vivo are needed to elucidate the optimum material, using 14 
porous 3D scaffolds of these MBGs, for bone tissue engineering applications.   15 
 16 
Figure 9. MC3T3-E1 cell number measured by CellTiter 96® AQueous assay in the 17 
presence of BL, 4ZN and 5ZN disks, loaded or not with 100 nM osteostatin, after 2 d (A) 18 
and 5 d (B) of culture. Absorbance was measured at 490 nm, directly proportional to the 19 
number of living cells. Runx2 mRNA levels measured by real-time PCR (C), ALP 20 
activity (D) and matrix mineralization measured by Alizarin red staining (E) in MC3T3-21 
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E1 cells in the presence of these materials at 5 d (C and D) and 12 d (E) of culture. For 1 
mineralization studies, absorbance was measured at 620 nm. Results are means ± SEM 2 
of three measurements in triplicate (*p<0.05) vs. corresponding unloaded disks.  3 
4. Conclusions 4 
The results obtained in this study provide a novel and interesting insight 5 
in the field of bioactive glasses for bone regeneration. MBG disks containing 4 6 
or 5% ZnO and decorated with osteostatin were shown to improve 7 
osteoblastic cell number as well as osteoblast differentiation capacity. For the 8 
first time, osteostatin was demonstrated to enhance the in vitro osteogenic 9 
capacity of Zn2+-enriched materials, suggesting the potential of this approach 10 
in bone tissue engineering applications. 11 
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